Clinical Trials

How Has Ajay Pasupulla Transformed Oral Cancer Research?
Research & Development How Has Ajay Pasupulla Transformed Oral Cancer Research?

Ajay Prakash Pasupulla stands as a pioneering force in the realm of oral and maxillofacial pathology, revolutionizing our understanding of oral cancer over a career spanning more than two decades. His journey began in Betamcherla, Andhra Pradesh, where he laid the foundation for a promising medical

Why Are Clinical Trials Key to Medical Advances at UAMS?
Management & Regulatory Why Are Clinical Trials Key to Medical Advances at UAMS?

Clinical trials stand as a cornerstone in the journey toward medical advancements, acting as the bridge that connects theoretical research with practical, patient-centered care. At the University of Arkansas for Medical Sciences (UAMS), clinical trials are a celebrated and integral part of

Can Liver Immunotherapy Transform Allergy Treatment?
Research & Development Can Liver Immunotherapy Transform Allergy Treatment?

Allergic diseases, particularly allergic rhinitis and asthma, significantly impact the lives of millions worldwide, necessitating groundbreaking research for more effective treatments. Traditional methods of allergen immunotherapy, which involve repeated exposure to allergens over time, often

How Can We Boost Psychosis Patient Recruitment in Clinical Trials?
Research & Development How Can We Boost Psychosis Patient Recruitment in Clinical Trials?

Recruiting patients diagnosed with psychosis for clinical trials poses distinct challenges due to the complexities associated with the disorder itself and systemic barriers within healthcare systems. Despite the significant need for advancing treatment methodologies for psychosis, the recruitment

Can IMNN-001 Transform Ovarian Cancer Treatment?
Research & Development Can IMNN-001 Transform Ovarian Cancer Treatment?

Ovarian cancer remains one of the most formidable challenges in the field of oncology, primarily due to its elusive early detection and late-stage diagnosis. The disease often only presents symptoms when it has reached an advanced stage, rendering many existing treatments less effective at

FDA Approves First Blood Test for Early Alzheimer's Detection
Management & Regulatory FDA Approves First Blood Test for Early Alzheimer's Detection

In a significant advancement for Alzheimer's disease diagnosis, the US Food and Drug Administration (FDA) has approved a new and groundbreaking diagnostic tool, the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio blood test. Developed by Fujirebio Diagnostics, this test offers a less invasive and

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later